Research Compensation and Enhanced Contacts in Studies With Persons Who Use Drugs: Lessons From the COVID-19 Pandemic Demand a Reset
| Autor: | Matthew G Lemansky, Anna K Martin, Judith A Bernstein, Sabrina A Assoumou |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Substance Abuse: Research and Treatment, Vol 17 (2023) |
| Druh dokumentu: | article |
| ISSN: | 1178-2218 11782218 |
| DOI: | 10.1177/11782218231179039 |
| Popis: | Policy changes resulting from the coronavirus 2019 (COVID-19) pandemic have had a substantial and positive impact on the clinical care of persons with opioid use disorder. These innovative paradigm shifts created a ripe environment for re-evaluating traditional approaches to recruiting and retaining persons who use drugs into research studies. For example, changes to methadone prescribing requirements and authorization of buprenorphine prescriptions via telehealth have both increased access to medications. In this commentary, we contribute to ongoing conversations about the ethics of compensation for participants in addiction-related clinical research and share methods of payment that proved successful in research performed during the pandemic. We also discuss approaches to enrollment and follow-up that were implemented during the height of COVID restrictions. These approaches may mutually benefit both participants and researchers in a post-pandemic era. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|